User profiles for Amanda Blackford

Amanda Blackford

Senior Data Scientist, Research Associate, Johns Hopkins University
Verified email at jhmi.edu
Cited by 12842

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma

…, S Jones, J Wu, CP Reynolds, X Liu, A Blackford… - Nature …, 2013 - nature.com
Neuroblastomas are tumors of peripheral sympathetic neurons and are the most common
solid tumor in children. To determine the genetic basis for neuroblastoma, we performed whole…

Egr-2 and Egr-3 are negative regulators of T cell activation

…, A Allen, CT Huang, J Kowalski, A Blackford… - Nature …, 2005 - nature.com
T cell receptor engagement in the absence of proper accessory signals leads to T cell anergy.
E3 ligases are involved in maintaining the anergic state. However, the specific molecules …

RNAi-Mediated Silencing of Nuclear Factor Erythroid-2–Related Factor 2 Gene Expression in Non–Small Cell Lung Cancer Inhibits Tumor Growth and Increases …

…, SK Rath, H Ashush, J Coulter, A Blackford… - Cancer research, 2008 - AACR
Nuclear factor erythroid-2–related factor 2 (Nrf2) is a redox-sensitive transcription factor that
regulates the expression of electrophile and xenobiotic detoxification enzymes and efflux …

SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer

A Blackford, OK Serrano, CL Wolfgang… - Clinical cancer …, 2009 - AACR
Purpose: Recently, the majority of protein coding genes were sequenced in a collection of
pancreatic cancers, providing an unprecedented opportunity to identify genetic markers of …

A combination of molecular markers and clinical features improve the classification of pancreatic cysts

…, M Dal Molin, DL Masica, Y Jiao, I Kinde, A Blackford… - Gastroenterology, 2015 - Elsevier
Background & Aims The management of pancreatic cysts poses challenges to both patients
and their physicians. We investigated whether a combination of molecular markers and …

Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance

…, JA Almario, RD Schulick, CJ Yeo, A Klein, A Blackford… - Gastroenterology, 2018 - Elsevier
Background & Aims Screening of individuals who have a high risk of pancreatic ductal
adenocarcinoma (PDAC), because of genetic factors, frequently leads to identification of …

PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer

SP Rowe, KJ Macura, E Mena, AL Blackford… - Molecular imaging and …, 2016 - Springer
Purpose Current standard of care conventional imaging modalities (CIM) such as X-ray
computed tomography (CT) and bone scan can be limited for detection of metastatic prostate …

Common variation at 2p13. 3, 3q29, 7p13 and 17q25. 1 associated with susceptibility to pancreatic cancer

…, WR Bamlet, MF Bijlsma, A Blackford… - Nature …, 2015 - nature.com
Pancreatic cancer is the fourth leading cause of cancer death in the developed world 1 . Both
inherited high-penetrance mutations in BRCA2 (ref. 2 ), ATM 3 , PALB2 (ref. 4 ), BRCA1 (ref…

Prediction of response to immune checkpoint inhibitor therapy using early-time-point 18F-FDG PET/CT imaging in patients with advanced melanoma

…, SP Rowe, EM Gonzalez, A Blackford… - Journal of Nuclear …, 2017 - Soc Nuclear Med
The purpose of this study was to evaluate 18 F-FDG PET/CT scanning as an early predictor
of response to immune checkpoint inhibitors (ICIs) in patients with advanced melanoma. …

Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages

J Yu, AL Blackford, M Dal Molin, CL Wolfgang… - Gut, 2015 - gut.bmj.com
Objective Although pancreatic ductal adenocarcinoma is considered a rapidly progressive
disease, mathematical models estimate that it takes many years for an initiating pancreatic …